spacer
home > pmps > spring 2017 > under control
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Under Control

A controlled substance is a drug or chemical whose manufacture, possession or distribution is highly regulated by the government and subject to legislative control. They include illegal drugs, prescription medications and chemicals considered as precursors to the production of illegal drugs. These are all believed to cause harm to an individual if not used properly. Their manufacture and distribution are closely monitored by the United Nations (UN).

The construction of an international legal framework for controlled drugs has gone through several stages of development since the 1920 alcohol prohibition in the US. In 1961, the Single Convention on Narcotic Drugs was established as a universal system to limit the cultivation, production, distribution, trade, use and possession of narcotic substances strictly for medical and scientific purposes, with special attention to those produced from plants.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Rich Nelson is the Distribution Services Manager for PCI’s Clinical Services group, working with clients to provide seamless global distribution of their investigational products. He joined the company in 2012 after seven years with Fisher Clinical Services, having supported both global distribution for investigational products, as well as interactive voice response solutions. Rich is certified in Lean Six Sigma/continuous improvement, including as a Small Group Facilitor/ Corporate Trainer, and is a graduate of Monmouth University, US.
spacer
Rich Nelson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

York Health Economics Consortium offers a new health utilities training course

Cost-utility analysis is a requirement for NICE health technology appraisals and is being increasingly used in other contexts and countries. Health utilities, a crucial component of cost-utility analysis, capture the relative change in health-related quality of life resulting from a treatment. As such, health utility can be a key driver of the cost-effectiveness ratio. Obtaining health utility values that are suitable for your economic evaluation, however, may not always be straight forward.
More info >>

White Papers

Accelerate Your Database Lock Using Clean Patient Optics

Bioclinica

Because a key step towards database lock is obtaining clean data for all patients, the ability to verify that data are clean early accelerates the ability to lock the clinical database. This ultimately shortens the overall study timeline while ensuring the quality of your data. However, this can be challenging when manually reviewing study data, particularly with larger studies.
More info >>

 
Industry Events

Pharmapack Europe 2018

7-8 February 2018, Hall 7.1, Paris Expo, Porte de Versailles, Paris.

As Europe's dedicated Pharmaceutical Packaging and Drug Delivery event, Pharmapack is the industry's go-to place to kick-off the year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement